150 related articles for article (PubMed ID: 12538746)
1. Serial estimates of serum permeability activity and clinical correlates in patients with native kidney focal segmental glomerulosclerosis.
Cattran D; Neogi T; Sharma R; McCarthy ET; Savin VJ
J Am Soc Nephrol; 2003 Feb; 14(2):448-53. PubMed ID: 12538746
[TBL] [Abstract][Full Text] [Related]
2. Permeability factors in focal segmental glomerulosclerosis.
Savin VJ; McCarthy ET; Sharma M
Semin Nephrol; 2003 Mar; 23(2):147-60. PubMed ID: 12704575
[TBL] [Abstract][Full Text] [Related]
3. Serum glomerular permeability activity in patients with podocin mutations (NPHS2) and steroid-resistant nephrotic syndrome.
Carraro M; Caridi G; Bruschi M; Artero M; Bertelli R; Zennaro C; Musante L; Candiano G; Perfumo F; Ghiggeri GM
J Am Soc Nephrol; 2002 Jul; 13(7):1946-52. PubMed ID: 12089392
[TBL] [Abstract][Full Text] [Related]
4. Sera from patients with collapsing focal segmental glomerulosclerosis increase albumin permeability of isolated glomeruli.
McCarthy ET; Sharma M; Sharma R; Falk RJ; Jennette JC
J Lab Clin Med; 2004 Apr; 143(4):225-9. PubMed ID: 15085081
[TBL] [Abstract][Full Text] [Related]
5. A randomized double-blind placebo-controlled trial of cyclosporine in steroid-resistant idiopathic focal segmental glomerulosclerosis in children.
Lieberman KV; Tejani A
J Am Soc Nephrol; 1996 Jan; 7(1):56-63. PubMed ID: 8808110
[TBL] [Abstract][Full Text] [Related]
6. The focal segmental glomerulosclerosis permeability factor: biochemical characteristics and biological effects.
Sharma M; Sharma R; McCarthy ET; Savin VJ
Exp Biol Med (Maywood); 2004 Jan; 229(1):85-98. PubMed ID: 14709781
[TBL] [Abstract][Full Text] [Related]
7. Plasmapheresis in the treatment of steroid-resistant focal segmental glomerulosclerosis in native kidneys.
Feld SM; Figueroa P; Savin V; Nast CC; Sharma R; Sharma M; Hirschberg R; Adler SG
Am J Kidney Dis; 1998 Aug; 32(2):230-7. PubMed ID: 9708606
[TBL] [Abstract][Full Text] [Related]
8. Proteinuria after injection of human focal segmental glomerulosclerosis factor.
Sharma M; Sharma R; Reddy SR; McCarthy ET; Savin VJ
Transplantation; 2002 Feb; 73(3):366-72. PubMed ID: 11884932
[TBL] [Abstract][Full Text] [Related]
9. Components of normal serum block the focal segmental glomerulosclerosis factor activity in vitro.
Sharma R; Sharma M; McCarthy ET; Ge XL; Savin VJ
Kidney Int; 2000 Nov; 58(5):1973-9. PubMed ID: 11044217
[TBL] [Abstract][Full Text] [Related]
10. Study of the in vitro effect on glomerular albumin permselectivity of serum before and after renal transplantation in focal segmental glomerulosclerosis.
Godfrin Y; Dantal J; Perretto S; Hristea D; Legendre C; Kreis H; Soulillou JP
Transplantation; 1997 Dec; 64(12):1711-5. PubMed ID: 9422407
[TBL] [Abstract][Full Text] [Related]
11. Janus kinase 2/signal transducer and activator of transcription 3 inhibitors attenuate the effect of cardiotrophin-like cytokine factor 1 and human focal segmental glomerulosclerosis serum on glomerular filtration barrier.
Sharma M; Zhou J; Gauchat JF; Sharma R; McCarthy ET; Srivastava T; Savin VJ
Transl Res; 2015 Oct; 166(4):384-98. PubMed ID: 25843671
[TBL] [Abstract][Full Text] [Related]
12. The effect of proteinase inhibitors on glomerular albumin permeability induced in vitro by serum from patients with idiopathic focal segmental glomerulosclerosis.
Carraro M; Zennaro C; Artero M; Candiano G; Ghiggeri GM; Musante L; Sirch C; Bruschi M; Faccini L
Nephrol Dial Transplant; 2004 Aug; 19(8):1969-75. PubMed ID: 15187198
[TBL] [Abstract][Full Text] [Related]
13. Indomethacin protects permeability barrier from focal segmental glomerulosclerosis serum.
McCarthy ET; Sharma M
Kidney Int; 2002 Feb; 61(2):534-41. PubMed ID: 11849393
[TBL] [Abstract][Full Text] [Related]
14. Prediction and treatment of recurrent focal segmental glomerulosclerosis after renal transplantation in children.
Dall'Amico R; Ghiggeri G; Carraro M; Artero M; Ghio L; Zamorani E; Zennaro C; Basile G; Montini G; Rivabella L; Cardillo M; Scalamogna M; Ginevri F
Am J Kidney Dis; 1999 Dec; 34(6):1048-55. PubMed ID: 10585314
[TBL] [Abstract][Full Text] [Related]
15. Proteinuria in focal segmental glomerulosclerosis: role of circulating factors and therapeutic approach.
Moriconi L; Lenti C; Puccini R; Pasquariello A; Rindi P; Batini V; Carraro M; Zennaro C
Ren Fail; 2001; 23(3-4):533-41. PubMed ID: 11499567
[TBL] [Abstract][Full Text] [Related]
16. Serum permeability activity in steroid-resistant minimal change nephrotic syndrome is abolished by treatment of Hodgkin disease.
Aggarwal N; Batwara R; McCarthy ET; Sharma R; Sharma M; Savin VJ
Am J Kidney Dis; 2007 Nov; 50(5):826-9. PubMed ID: 17954296
[TBL] [Abstract][Full Text] [Related]
17. A randomized trial of cyclosporine in patients with steroid-resistant focal segmental glomerulosclerosis. North America Nephrotic Syndrome Study Group.
Cattran DC; Appel GB; Hebert LA; Hunsicker LG; Pohl MA; Hoy WE; Maxwell DR; Kunis CL
Kidney Int; 1999 Dec; 56(6):2220-6. PubMed ID: 10594798
[TBL] [Abstract][Full Text] [Related]
18. Nephrotic urine prevents increased rat glomerular albumin permeability induced by serum from the same patient with idiopathic nephrotic syndrome.
Carraro M; Zennaro C; Candiano G; Musante L; Bruschi M; Ghiggeri GM; Artero M; Faccini L
Nephrol Dial Transplant; 2003 Apr; 18(4):689-93. PubMed ID: 12637636
[TBL] [Abstract][Full Text] [Related]
19. Cyclosporine-based immunosuppressive therapy for patients with steroid-resistant focal segmental glomerulosclerosis: a meta-analysis.
Chiou YY; Lee YC; Chen MJ
Curr Med Res Opin; 2017 Aug; 33(8):1389-1399. PubMed ID: 28436233
[TBL] [Abstract][Full Text] [Related]
20. Proteinuria Reduction and Kidney Survival in Focal Segmental Glomerulosclerosis.
Troost JP; Trachtman H; Spino C; Kaskel FJ; Friedman A; Moxey-Mims MM; Fine RN; Gassman JJ; Kopp JB; Walsh L; Wang R; Gipson DS
Am J Kidney Dis; 2021 Feb; 77(2):216-225. PubMed ID: 32791086
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
